Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
doi: 10.1016/j.bone.2014.07.030 18 DriessenJHvan OnzenoortHAStarup-LindeJHenryRNeefCvan den BerghJet al
Observed findings depend on route, formulation, concentration, and study design
The two drugs are FDA-approved for the treatment of type 2 diabetes and for weight loss
To determine whether this was true, researchers pooled data from observational studies and clinical trials that included type 2 diabetes patients taking a GLP-1RA.On average, 66.7% of patients taking GLP-1RAs also took a long-acting insulin (mean dose, 0.42 +- 0.32 units/kg/d)
US$ 23.36
US$ 28.21
US$ 24.69
US$ 25.27
